Paper42548876
Association between peripheral blood T cell subsets and clinical disability in multiple sclerosis patients.
Liu P and 3 others. Front Neurol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Association between peripheral blood T cell subsets and clinical disability in multiple sclerosis patients. Papers, record 42548876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42548876
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association between peripheral blood T cell subsets and clinical disability in multiple sclerosis patients.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41176941 | CAR T cells for multiple sclerosis: Engineering T cells to disrupt chronic B cell-driven neuroinflammation. | Mult Scler Relat Disord | 2025 | https://conductscience.org/library/papers/41176941 | PubMed |
| 2 | 29275977 | Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. | Lancet Neurol | 2018 | https://conductscience.org/library/papers/29275977 | PubMed |
| 3 | 30737333 | Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. | Neurology | 2019 | https://conductscience.org/library/papers/30737333 | PubMed |
| 4 | 16510744 | A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16510744 | PubMed |
| 5 | 38789516 | The neuropathobiology of multiple sclerosis. | Nat Rev Neurosci | 2024 | https://conductscience.org/library/papers/38789516 | PubMed |
| 6 | 24666846 | Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. | BMC Neurol | 2014 | https://conductscience.org/library/papers/24666846 | PubMed |
| 7 | 35115728 | Blood GFAP as an emerging biomarker in brain and spinal cord disorders. | Nat Rev Neurol | 2022 | https://conductscience.org/library/papers/35115728 | PubMed |
| 8 | 31611252 | Pathogenic T cell cytokines in multiple sclerosis. | J Exp Med | 2020 | https://conductscience.org/library/papers/31611252 | PubMed |
| 9 | 32106536 | Memory CD4+ T Cells in Immunity and Autoimmune Diseases. | Cells | 2020 | https://conductscience.org/library/papers/32106536 | PubMed |
| 10 | 29873694 | The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. | Brain | 2018 | https://conductscience.org/library/papers/29873694 | PubMed |
| 11 | 31941953 | Pre-treatment T-cell subsets associate with fingolimod treatment responsiveness in multiple sclerosis. | Sci Rep | 2020 | https://conductscience.org/library/papers/31941953 | PubMed |
| 12 | 29358322 | B-Cell Therapies in Multiple Sclerosis. | Cold Spring Harb Perspect Med | 2019 | https://conductscience.org/library/papers/29358322 | PubMed |
| 13 | 29576504 | Multiple sclerosis. | Lancet | 2018 | https://conductscience.org/library/papers/29576504 | PubMed |
| 14 | 32801039 | The role of TH17 cells in multiple sclerosis: Therapeutic implications. | Autoimmun Rev | 2020 | https://conductscience.org/library/papers/32801039 | PubMed |
| 15 | 28288125 | Regulatory T cells promote myelin regeneration in the central nervous system. | Nat Neurosci | 2017 | https://conductscience.org/library/papers/28288125 | PubMed |
| 16 | 32440353 | Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis. | Mult Scler J Exp Transl Clin | 2020 | https://conductscience.org/library/papers/32440353 | PubMed |
| 17 | 38354532 | Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management. | EBioMedicine | 2024 | https://conductscience.org/library/papers/38354532 | PubMed |
| 18 | 24871874 | Defining the clinical course of multiple sclerosis: the 2013 revisions. | Neurology | 2014 | https://conductscience.org/library/papers/24871874 | PubMed |
| 19 | 31937773 | Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. | Nat Commun | 2020 | https://conductscience.org/library/papers/31937773 | PubMed |
| 20 | 6685237 | Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). | Neurology | 1983 | https://conductscience.org/library/papers/6685237 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42548876
GET https://conductscience.org/api/papers/v1/42548876/references?page=2